Peking University People's Hospital, Beijing, China.
Ren Fail. 2013;35(2):231-4. doi: 10.3109/0886022X.2012.747132. Epub 2013 Feb 4.
To compare overall survival and technical survival in diabetic mellitus (DM) and non-DM (N-DM) Chinese patients undergoing peritoneal dialysis (PD), and to discuss the factors involved.
Clinical data were analyzed for all adult patients (age >18 years) with chronic renal failure who had commenced PD between 2006 and 2010 in a single Chinese center.
Compared to the N-DM group, the DM group was older (64.5 ± 11.9 years vs. 59.2 ± 15.2 years, p = 0.023), with a higher body mass index (BMI) (25.2 ± 3.5 kg/m(2) vs. 23.2 ± 3.5 kg/m(2), p = 0.001), a higher estimated glomerular filtration rate (eGFR) (10.4 ± 4.7 mL/min/1.73 m(2) vs. 6.9 ± 2.9 mL/min/1.73 m(2), p = 0.000), and lower intact parathyroid levels (81.35 pg/mL vs. 186.3 pg/mL, p = 0.003). During the average 23.8-month follow-up period, the 1-, 2-, and 3-year survival rates of the DM group were 95.8%, 69.2%, and 60%, respectively. The 1-, 2-, and 3-year survival rates of the N-DM group were 87.2%, 76.5%, and 66.7%, respectively. There was no significant difference in survival between the groups. The 1-, 2-, and 3-year technical survival rates of the DM group were 93.8%, 69.2% and 60%, respectively. The 1-, 2-, and 3-year technical survival rates of the N-DM group were 84.6%, 72.5% and 63.3%, respectively. There was no significant difference in technical survival between the groups. Within the DM group, the only factor predictive for both overall survival (p = 0.015) and technical survival (p = 0.009) was the initial BMI, and both survival outcomes in DM patients with a BMI greater than 24 were higher than those observed with a BMI less than 24.
In the first 3 years of PD, DM and N-DM patients have similar survival rates. Chinese DM patients with a higher BMI undergoing PD appear to have higher survival rates than those with a lower BMI.
比较中国糖尿病(DM)和非糖尿病(N-DM)腹膜透析(PD)患者的总生存率和技术生存率,并探讨相关因素。
对 2006 年至 2010 年间在中国某单一中心接受 PD 的所有成年慢性肾衰竭患者(年龄>18 岁)的临床数据进行分析。
与 N-DM 组相比,DM 组年龄更大(64.5±11.9 岁比 59.2±15.2 岁,p=0.023),体重指数(BMI)更高(25.2±3.5 kg/m²比 23.2±3.5 kg/m²,p=0.001),估算肾小球滤过率(eGFR)更高(10.4±4.7 mL/min/1.73 m²比 6.9±2.9 mL/min/1.73 m²,p=0.000),全段甲状旁腺激素水平更低(81.35 pg/mL 比 186.3 pg/mL,p=0.003)。在平均 23.8 个月的随访期间,DM 组的 1、2 和 3 年生存率分别为 95.8%、69.2%和 60%。N-DM 组的 1、2 和 3 年生存率分别为 87.2%、76.5%和 66.7%。两组之间的生存率无显著差异。DM 组的 1、2 和 3 年技术生存率分别为 93.8%、69.2%和 60%。N-DM 组的 1、2 和 3 年技术生存率分别为 84.6%、72.5%和 63.3%。两组之间的技术生存率无显著差异。在 DM 组中,唯一预测总生存率(p=0.015)和技术生存率(p=0.009)的因素是初始 BMI,并且 BMI 大于 24 的 DM 患者的两种生存结局均高于 BMI 小于 24 的患者。
在 PD 的前 3 年,DM 和 N-DM 患者的生存率相似。中国 BMI 较高的 DM 患者接受 PD 后,生存率似乎高于 BMI 较低的患者。